Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Announces Date of Make-Whole Fundamental Change

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore said today that with the completion of its purchase by Merck KGaA, it is delivering a notice to holders of its 3.75 percent Convertible Senior Notes due 2026 that the effective date of the Make-Whole Fundamental Change was July 14, when the deal was completed.

The purchase's completion also triggered an increase in the conversion rate "applicable to notes surrendered for conversion during the Make-Whole Conversion period," Millipore said.

As a result of the Make-Whole Fundamental Change, the conversion rates applicable to notes surrendered for conversion during the Make-Whole Convertibility period is being increased to 0.7519 shares per $1,000 principal amount of notes, resulting in an additional cash payment of $80.46 for each $1,000 in principal amount of notes.

Holders of such notes must surrender them during the Make-Whole Conversion period, which began on June 14 and ends the latter of Aug. 25 and the "Fundamental Change Repurchase Date, which Millipore will announce within 20 business days after consummation of the share exchange.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.